Johnson & Johnson Surgical Vision, Inc.

This study tested a gel called Healon EndoCoat, which is used during cataract surgery to protect the eye and keep it stable. Researchers compared a new version of the gel to the current version in 165 people having cataract surgery in both eyes. The goal was to see if the new gel…

This study tested a new laser system called Cheetah to correct nearsightedness (myopia) with or without astigmatism. About 286 adults with mild to moderate nearsightedness received the treatment. The main goal was to see how many patients achieved clear vision without glasses one…

This study tested a new type of artificial lens (TECNIS Next-Generation) in 245 adults with cataracts in both eyes. The goal was to see if the new lens provides better vision at intermediate and near distances compared to a standard lens. Participants received the lens during rou…

This study looks at how much an artificial lens (implanted during cataract surgery) tilts or shifts out of place. Researchers will use a special camera to take detailed images of the lens in about 80 adults who had surgery at least three months ago. The goal is to gather informat…

This study looked at 307 cataract patients who received a special lens called TECNIS PC IOL to correct both cataracts and presbyopia (age-related blurry near vision). Researchers collected information from medical records and questionnaires to see how well patients saw, how satis…

This study looked at different methods to measure how well an artificial lens stays centered and aligned in the eye after cataract surgery. It involved 53 adults who had already received a specific type of lens implant. The goal was to compare measurement techniques, not to test …

This study looked at 79 adults who already had a specific type of artificial lens implant (TECNIS monofocal or Eyhance IOL). The goal was to compare two methods for measuring depth of focus: using trial lenses versus a chart at different distances. No new treatment was given; the…

This study tested how well a new device (ELITA) docks onto the eye for refractive error treatment. 55 adults participated to see if the docking procedure works correctly. The study did not provide treatment, only measured the device's performance.